Methods

Patients
We enrolled 29 consecutive AADa patients (AADa group) and 49 consecutive AMI patients (AMI group) from January 2001 until December 2003. All patients were admitted to Osaka Mishima Emergency and Critical Care Center within 4 h of the onset of symptoms. Ten patients received heparin before arrival at the hospital and were excluded from this study. A chest radiograph, ECG and blood tests were performed for each patient immediately after admission. Diagnosis of AMI was defined as confirmation of the infarct-related artery by coronary angiography and subsequent elevation of the CK isozyme MB (MB) to more than twice the upper normal limit. Diagnosis of AADa was confirmed by chest and abdominal enhanced computed tomography.
Clinical Record Review
After approval by the Human Research Committee of the hospital, we reviewed the clinical records of each patient. We reviewed the time from the onset of symptoms to admission (TIME) and examined the results for myoglobin, CK, MB, LDH, WBC, Ht and D-dimer (Latex agglutination, Roche Diagnostic, Tokyo, Japan; measurement range: 0.22-4.5 g/ml, normal limit ≤0.4 g/ml, measurement time: ≈15 min) and calculated the M-ratio. An anteroposterior chest radiograph with the focal point set at 110 cm above the body surface was taken while the patients were supine in the emergency room.
Statistical Analysis
The frequency and percentage for the categorical data were determined. For continuous variables, the 25% and 75% percentiles, median, mean and standard deviation were calculated. Comparison of continuous variables between 2 groups was performed using a Mann-Whitney U test. Comparison of demographic variables for categorical data was performed using a chi-square or the Fischer exact test, as appropriate. Correlation between 2 data sets was estimated by a Spearman correlation. A value of p<0.05 was considered to be significant. Moreover, receiver-operating characteristic (ROC) curves were constructed after calculation of the sensitivity for AADa and AMI to determine the best cutoff value. The area under the curve (AUC) was also calculated and shown with 95% confidence interval (CI). All statistical calculations were performed with commercially available statistical software (SPSS II for Windows, Version 11.0; Chicago, IL, USA).
Results
Baseline Characteristics
The clinical differences between the AADa and AMI patients are shown in Table 1 . The AADa group had significantly comprised fewer male patients, less history of smoking and diabetes mellitus, a greater occurrence of hypertension, and a lower total cholesterol concentration, compared with the AMI patients. Differences in age, and in the incidence of shock, ventricular fibrillation, atrial fibrillation or renal dysfunction were not significant between the 2 groups.
Six of the AADa patients presented with ST changes on the ECG (2 of the 6 showed both ST elevation and ST depression), and 6 of the AMI patients did not present with ST elevation. The AADa group included 13 patients with a thrombosed false lumen and 16 with a patent false lumen, and 23 patients with Debakey type I (contained Debakey type retrograde IIIb) and 6 patients with Debakey type II.
Clinical Data
There were no significant differences in TIME, myoglobin or WBC between the 2 groups ( Table 2 ). In the AADa group, the concentrations of LDH and D-dimer and the Mratio were significantly higher, and those of CK, MB and Ht were significantly lower than the AMI group ( Table 2 , Fig 1) .
The sensitivities for AADa and AMI of each cutoff value were calculated and used to construct the ROC curves (Fig 2) the M-ratio were set to 0.8 or 0.9 g/ml and 0.309, respectively, the sensitivity for AADa is 93.1% and 93.1%, respectively, and the sensitivity for AMI is 91.8% and 85.7%, respectively (Fig 2) . Hence, this indicates that AADa patients should have a D-dimer concentration >0.8 or 0.9 g/ml and an M-ratio >0.309. 
Cutoff Value for the D-Dimer Concentration
No significant correlation between the D-dimer concentration and TIME was obtained in either group (AADa group; r=-0.077, p=0.690, AMI group; r=-0.225, p=0.120; Fig 3) , suggesting that elevation of D-dimer does not depend on TIME. The sensitivity for AADa was 93.8% during the first 90 min after the onset of symptoms, 90.9% in the following 90 min, and 100% beyond 180 min. There were 2 patients with a D-dimer concentration <0.8 g/ml in the AADa group, and 4 patients with a D-dimer concentration >0.9 g/ml in the AMI group. The 2 patients with a D-dimer concentration <0.8 g/ml in the AADa group had a thrombosed false lumen, so the sensitivity with or without a thrombosed false lumen was 84.6% or 100%, respectively. In addition, the D-dimer value was significantly lower in patients with a thrombosed false lumen than with a patent false lumen (10.1±15.4 g/ml vs 73.9±80.7 g/ml, p=0.001) and in patients with Debakey type II than with Debakey type I, indicating that the D-dimer value depends on the length of the dissection (2.0±1.0 g/ml vs 56.6±72.5 g/ml, p=0.004). However, patients with Debakey type II tended more often to have a thrombosed false lumen than patients with Debakey type I (66.6% vs 39.1%, p=0.364).
Cutoff Value for the M-Ratio
There were 2 patients with an M-ratio <0.309 in the AADa group and 7 patients with an M-ratio >0.309 in the AMI group. The M-ratio was also shown to be independent of TIME (data not shown).
Sensitivity for AADa
The correlation between the D-dimer concentration and the M-ratio was examined, and this is plotted in Fig 4. No significant correlation was obtained in AADa group (AADa group; r=0.041 p=0.831, AMI group; r=0.474 p=0.001). Both AADa patients with a D-dimer concentration <0.8 g/ml showed an M-ratio >0.309 (0.390 and 0.315, respectively), and 2 other patients with an M-ratio <0.309 had a D-dimer concentration >0.9 g/ml (9 g/ml and 2.7 g/ml, respectively).
Hence, simultaneous use of the original cutoff values for the D-dimer concentration or M-ratio gives a sensitivity of 100% for AADa.
Discussion
In the present study, the D-dimer concentration and the M-ratio were shown to have high sensitivity for AADa and AMI. These are parameters that can be determined promptly and inexpensively, and hence they may have potential as tests that can be routinely performed for exclusion of AADa before initiation of reperfusion therapy for patients diagnosed with AMI.
D-Dimer Concentration
We propose that setting the cutoff value for the D-dimer beyond the normal limit, instead of the upper limit of normal, is important for discriminating between AMI and AADa. 24 A previous report, which showed the efficacy of the D-dimer assay as a screening test for aortic dissection, set the cutoff value at the upper limit of normal 19 and in the present study there were 10 AMI patients (20.4%) with a D-dimer value beyond that value and 2 AADa patients (6.9%) with a D-dimer value less than it (ie, 100% sensitivity for AADa could not be achieved). Moreover, the incidence of cases of AMI that need urgent reperfusion therapy is more frequent than AADa, 6, 25 so the test requires high sensitivity not only for AADa but also for AMI.
Suzuki et al reported that the sensitivity of a rapid 30-min assay for myosin heavy chain decreased with time; 100% for AADa patients within 3 h of the onset of symptoms, 83.3% for 3-6 h of onset, and 41.1% beyond 6 h, and the sensitivity for AMI patients was 83.0%. 16 As the half-life of D-dimer is approximately 8 h, 26 D-dimer has an advantage over myosin heavy chain in differentiating AADa from AMI.
Another previous report 27 supports our finding that the D-dimer concentration is influenced by the presence of a thrombosed false lumen, but there was not an excessive deterioration of sensitivity for AADa in cases with a thrombosed false lumen. Shinohara et al reported that the sensitivity of the soluble elastin fragment for aortic dissection with and without a thrombosed false lumen was 0% and 88.9%, respectively. 18 These results indicate that the Ddimer assay also has an advantage over measurement of the soluble elastin fragment.
With regard to the mechanisms underlying the elevation of D-dimer in AADa, some reports have shown the presence of a tissue factor in the smooth muscle layer of the aorta, with this factor being abundant following progression of atherosclerotic changes. 28, 29 In AADa, this tissue factor would pour into the bloodstream where it would activate the coagulation cascade, stimulating fibrinolytic activity and the formation of D-dimer. 30 Moreover, in patients with a thrombosed false lumen, fresh thrombi in the lumen 31 may also cause an elevation of the D-dimer concentration through activation of the fibrinolytic system.
The D-dimer concentration tends to be elevated in many diseases, such as pulmonary embolism, 32 deep venous thrombosis, 33,34 disseminated intravascular coagulation, 35 cancer, 36 ventricular tachycardia and fibrillation, 23 congestive heart failure 23,37 and atrial fibrillation. 38, 39 Therefore, further investigation is necessary to clarify whether the Ddimer assay can differentiate AADa from these diseases, but we believe that by setting an appropriate cutoff value for the assay AADa can be differentiated from AMI in the emergency department before initiation of reperfusion therapy, even if the D-dimer value is not diagnostic for AADa because of its lack of specificity. 24 
M-Ratio
The findings on plain chest radiographs that are suggestive of AADa include tracheal displacement, an indistinct arch, abnormal aortic contour, separation of calcification, and a wide mediastinum. 2, 4, 25 Although a definition of an abnormally widened mediastinum on a plain chest radiograph has been used as the M/C ratio 40 for exclusion of blunt aortic injury, an equivalent definition has not been developed for exclusion of AADa, as far as we are aware. Klompas reported a large variation (from 11% to 94%) in the incidence of a widened mediastinum in AADa, 2 so in the present study we introduced the M-ratio. Interestingly, there was no correlation between the D-dimer concentration and the M-ratio in AADa patients, and simultaneous use of our cutoff values for the D-dimer concentration (0.8 or 0.9 g/ml) or M-ratio (0.309) gave a sensitivity of 100%. If we take into account the occasional AADa patient in whom either the D-dimer or M-ratio is beyond the cutoff values, and for AMI on the occasion that both the D-dimer and M-ratio are below the cutoff values, the sensitivity for AADa and AMI is 100% and 81.6%, respectively.
Other Blood Components
In this study, there were significant differences in CK, MB, LDH and Ht between the AMI and AADa groups, but it was impossible to discriminate between them using the cutoff values for these blood components.
Study Limitations
Our study group comprised patients who had been already diagnosed with AMI or AADa, which is different to the clinical setting. We have to compare AMI patients with AADa patients who have similar symptoms and ST displacement on the ECG at least to achieve the primary purpose of our study. However, we could not design such a study because the number of AADa patients who satisfied our criteria was very small. In addition, our study has a relatively small number of patients, is retrospective and patients with acute aortic dissection of the descending aorta only (AADb) were excluded. However, it is more important for physicians to differentiate AADa than AADb from AMI before performing coronary reperfusion therapy. We regard our study as the first step to setting the cutoff value for discrimination between AMI patients and AADa patients or to detect patients with aortic dissection from patients with chest pain. Our result must be reconfirmed in a prospective and large trial of patients with chest pain and ST displacement on ECG similar to AMI. Our study, which evaluated patients within 4 h of the onset of symptoms, also has a temporal limitation for the importance of CK and MB, which mainly begin to be elevated from 6 h after the onset of symptoms in AMI patients.
Conclusions
Through the setting of appropriate cutoff values (Ddimer: 0.8 or 0.9 g/ml; M-ratio: 0.309), these 2 simple tests can be routinely used for exclusion of AADa patients prior to reperfusion therapy for patients diagnosed with AMI. We recommend considering AADa if either the D-dimer or M-ratio value is beyond our suggested cutoff values and AMI if both the D-dimer and M-ratio values are below the cutoff values.
